In the originally published version of this article, the sentence “A study with carboplatin plus nab-paclitaxel with and without nintedanib demonstrated that addition of nintedanib prolongs the interval to acute exacerbation [108]” should have stated “A study with carboplatin plus nab-paclitaxel with and without nintedanib was designed to demonstrate that addition of nintedanib prolongs the interval to acute exacerbation [108]. The results of this trial are expected soon.” This has been corrected in the article itself.
- Copyright ©ERS 2022
http://creativecommons.org/licenses/by-nc/4.0/
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
Vol 8 Issue 3
Table of Contents
“Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges”. Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour. ERJ Open Res 2022; 8: 00115-2022.
